Rhizocore Technologies

Cover Block

PUBLIC

Name	Rhizocore Technologies
Tagline	Locally-adapted mycorrhizal fungi pellets for tree planting success
Headquarters	Edinburgh, United Kingdom
Founded	2021
Stage	Series A
Business Model	B2B
Industry	Cleantech / Climatetech
Technology	Biotech / Life Sciences
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Academic Spinout
Funding Label	Series A (total disclosed ~$4,810,000)

Links

PUBLIC

• Website: https://www.rhizocore.com
• LinkedIn: https://uk.linkedin.com/in/jack-hooper-a21422ba

Executive Summary

PUBLIC

Rhizocore Technologies is an applied mycology company that has developed a proprietary, site-specific fungal pellet to improve tree survival rates in degraded soils, a proposition gaining urgency as large-scale reforestation and carbon projects face persistent establishment challenges [Rhizocore Technologies Ltd]. The company spun out of the Roslin Institute at the University of Edinburgh in 2021, leveraging a deep scientific library of ectomycorrhizal fungi to create its RhizoPellets™, which form symbiotic networks with tree roots to enhance nutrient and water uptake [Edinburgh Innovations]. Founder Dr. Toby Parkes, a plant scientist with a PhD in Biochemistry and prior research at the Royal Botanic Gardens, Kew, anchors the technical credibility of the venture [Rhizocore Technologies Ltd].

Its business model targets B2B sales to forestry, restoration, and carbon capture initiatives, with a notable anchor customer and investor in The Grosvenor Estate, one of the UK's largest landowners [Roslin Innovation Centre]. A recent £4.5 million Series A round led by specialist soil health investor First Thirty is funding a tenfold production scale-up in the UK and the establishment of a commercial hub in Atlanta for North American expansion [GlobeNewswire, Nov 2025]. Over the next 12-18 months, the key watchpoints are the commercial validation of its localized product approach in new geographies, the scaling of its production and field operations to meet stated goals, and the translation of early trial success into repeatable, large-contract revenue.

Data Accuracy: YELLOW -- Core company claims and recent funding are confirmed by multiple sources; some traction metrics (e.g., pellet count) are company-reported only.

Taxonomy Snapshot

Axis	Classification
Stage	Series A
Business Model	B2B
Industry / Vertical	Cleantech / Climatetech
Technology Type	Biotech / Life Sciences
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Academic Spinout
Funding	Series A (total disclosed ~$4,810,000)

Company Overview

PUBLIC

Rhizocore Technologies was founded in 2021 as an applied mycology company, a spinout from the Roslin Institute and the University of Edinburgh's Deep Science Venture programme [Edinburgh Innovations]. The company is registered in Scotland as Rhizocore Technologies Ltd (SC704085) and is headquartered at the Roslin Innovation Centre on the University of Edinburgh's Easter Bush campus [GOV.UK]. Founder Dr. Toby Parkes, a plant scientist with a PhD in Biochemistry and a research background at the Royal Botanic Gardens, Kew, established the firm to commercialize research on symbiotic fungi for environmental restoration [Rhizocore Technologies Ltd].

Key operational milestones have followed a path from academic validation to commercial field testing. The company secured early-stage investment from the University of Edinburgh's in-house fund, Old College Capital, which provided support at launch and through subsequent scaling [Edinburgh Innovations]. By late 2025, Rhizocore reported operating more than 100 active field sites across the UK, where its RhizoPellets are deployed in partnership with entities like Forestry and Land Scotland and the Borders Forest Trust [Edinburgh Innovations] [The Scottish Farmer] [Mossy Earth]. A significant commercial milestone was securing The Grosvenor Estate as both a customer and an investor, providing a referenceable anchor client among UK landowners [Roslin Innovation Centre].

The most recent and material development is a £4.5 million (approximately $5.5 million) Series A funding round, led by specialist investor First Thirty and announced in November 2025 [GlobeNewswire, Nov 2025]. This capital is earmarked for a tenfold expansion of UK production capacity, a 50% increase in headcount, and the establishment of a commercial hub in Atlanta, Georgia, to drive North American market entry [Scottish Enterprise Media Centre] [UK Agri-Tech Centre].

Data Accuracy: GREEN -- Company registration, founding details, and recent funding confirmed by multiple public registries and news outlets.

Product and Technology

MIXED

The core product is a physical pellet designed to be a direct, low-fuss replacement for standard tree planting. Rhizocore Technologies sells RhizoPellets™, a proprietary formulation of locally-adapted ectomycorrhizal (ECM) fungi [Rhizocore Technologies Ltd]. The company's public framing emphasizes ease of use: the pellets are applied during planting to help young saplings establish symbiotic fungal networks in degraded soils where those networks are absent [Rhizocore Technologies Ltd].

Differentiation rests on a specific biological focus and a curated library. The company states it is the only entity applying ectomycorrhizal fungi in forestry, a subgroup that associates with roughly 10% of tree species, including many commercially and ecologically important varieties like oak, pine, and birch [Rhizocore Technologies Ltd]. Its production begins with a "living fungal library," described as one of the world's largest, from which strains are selected and cultivated for specific site conditions [Rhizocore Technologies Ltd, Edinburgh Innovations]. This localization is a repeated claim, though the precise method for matching fungi to site is not detailed in public materials.

Public traction is measured in field deployments and pellet counts. The company reports over 100 active field sites [Edinburgh Innovations] and more than 500,000 RhizoPellets planted to date [Rhizocore Technologies Ltd]. Early validation comes from named trials, including work with Forestry and Land Scotland that reported increased survival rates at a Damside site [The Scottish Farmer] and a mountain birch restoration project for the Borders Forest Trust run by Mossy Earth [Mossy Earth]. The product's stated mechanism is to enhance nutrient and water absorption for trees, thereby accelerating ecosystem recovery [Rhizocore Technologies Ltd].

Data Accuracy: YELLOW -- Product claims and trial participation are confirmed by multiple sources including the company website and third-party case studies. The 500,000+ pellets planted metric is a company-only claim. The biological differentiation claim ("only company utilizing mycorrhizal fungi in forestry") is a competitive statement not independently verified.

Market Research

PUBLIC The market for nature-based solutions is expanding beyond simple tree-planting to encompass the biological infrastructure needed to ensure those trees survive and thrive.

Third-party sizing for the specific niche of mycorrhizal forestry inoculants is not publicly available in the cited research. The broader market context, however, is defined by two converging forces: the scale of global reforestation commitments and the persistent challenge of tree mortality in degraded soils. The Bonn Challenge, a global effort to restore 350 million hectares of deforested and degraded land by 2030, provides a proxy for potential demand [The Bonn Challenge]. In the UK, government targets aim to increase woodland cover from 13% to 17% by 2050, a goal that requires planting at least 30,000 hectares annually [UK Government]. These targets create a clear, policy-driven SAM for forestry restoration services.

Demand drivers are both commercial and ecological. The voluntary carbon market, where forestry projects are a major category, continues to grow despite pricing volatility, creating a direct economic incentive for higher project success rates [Ecosystem Marketplace]. Concurrently, large landowners and asset managers face increasing pressure to demonstrate genuine ecological additionality and long-term stewardship, moving beyond mere hectare counts. This shifts focus to technologies that improve survival rates and accelerate canopy closure, which directly impacts carbon sequestration models and land valuation.

Key adjacent markets include the broader agricultural biostimulant sector, which was valued at approximately $3.2 billion globally in 2022 and is projected to grow at a compound annual rate of 11.5% [Fortune Business Insights]. While focused on row crops, this analogous market demonstrates established commercial pathways and customer willingness to pay for microbial products that enhance plant health and yield. The primary substitute is conventional forestry practice, which relies on soil conditioning, manual maintenance, and high-density planting to account for expected losses, often at a significant recurring cost.

Regulatory and macro forces are broadly supportive but introduce complexity. In the UK and EU, biodiversity net gain regulations and sustainable finance taxonomies are beginning to assign tangible value to ecosystem services, potentially creating new revenue streams for proven restoration technologies. The planned North American expansion, however, will require navigating a patchwork of state-level agricultural import regulations and federal forestry guidelines, which can slow commercial deployment.

Data Accuracy: YELLOW -- Market sizing relies on analogous sector reports and government policy targets; specific TAM for forestry inoculants is not independently verified.

Competitive Landscape

MIXED Rhizocore Technologies positions itself not against other fungal inoculant makers, but against the baseline practice of planting trees without any microbial enhancement.

A direct, named competitor is not present in the public record. The competitive map is therefore defined by alternative approaches to achieving forest restoration and commercial forestry goals. The landscape can be segmented into three categories: biological inputs, mechanical or chemical soil amendments, and project design services that bypass the need for soil enhancement.

• Biological Inputs. This is Rhizocore's primary category, though it claims a specific niche. Generalist mycorrhizal inoculant companies, such as those serving agriculture and horticulture (e.g., Mycorrhizal Applications, Lallemand), offer broad-spectrum products but do not specialize in forestry-specific ectomycorrhizal (ECM) fungi [Rhizocore Technologies Ltd]. The company's defensible edge today is its proprietary library of locally-adapted ECM strains and its focus on the symbiotic networks of the 10% of trees most critical for forestry. This edge is durable if the library's genetic diversity and field performance data create a compounding advantage that is difficult to replicate quickly. However, it is perishable if a larger agri-input player acquires similar academic IP or if field trial results fail to demonstrate consistent, measurable survival rate improvements at commercial scale.
• Soil Amendments & Services. Competitors here include companies selling biochar, fertilizers, or specialized planting techniques. Their value proposition is often broader soil health, not a specific fungal symbiosis. Rhizocore is most exposed in this segment because its product is a single component of a complex soil system; a land manager facing degraded soil might opt for a more holistic, multi-faceted amendment approach, viewing a fungal pellet as an unproven or incremental addition.
• Project Design & Species Selection. Some forestry consultancies and carbon project developers compete by advocating for different tree species or planting methodologies that are inherently more resilient, thereby reducing the perceived need for any additive. Rhizocore does not own this high-level advisory channel, which is a strategic vulnerability. Its success depends on convincing these specifiers that its pellets are a necessary, ROI-positive input for their chosen species on challenging sites.

The most plausible 18-month competitive scenario hinges on validation at scale in North America. If Rhizocore's US expansion yields published, third-party trial data showing significantly higher survival rates for high-value timber or carbon project species, it becomes the de facto specialist for ECM-dependent forestry. The winner in this scenario is Rhizocore, as it would solidify its niche and attract partnership interest from major timber investment managers. The loser would be the generic inoculant providers attempting to sell into forestry without the tailored data, as they would be relegated to commodity status. Conversely, if the North American trials are inconclusive or fail to outperform simpler, cheaper amendments, the company risks being pigeonholed as a regional solution for UK-specific conditions, ceding the larger market to integrated soil health platforms.

Data Accuracy: YELLOW -- Competitive analysis is inferred from company positioning and general market knowledge; no direct competitors are named in captured sources.

Opportunity

PUBLIC The prize for a company that can reliably and scalably improve tree survival rates is a dominant position in the multi-billion dollar ecosystem restoration and carbon project supply chain.

The headline opportunity is to become the de facto biological input for large-scale forestry and reforestation projects globally, analogous to how seed genetics or precision irrigation became foundational in agriculture. Rhizocore's evidence for this reachable outcome rests on its early traction with a critical customer segment: major landowners. The Grosvenor Estate, one of the UK's largest private landowners, is both a customer and an investor, a dual validation that signals product-market fit within a high-value, referenceable client base [Roslin Innovation Centre]. Furthermore, the company's technology is already deployed across more than 100 active field sites and has been used in trials with public bodies like Forestry and Land Scotland, where it reportedly increased survival rates [Edinburgh Innovations, The Scottish Farmer]. This moves the proposition from a lab concept to a field-tested solution with documented, albeit early, efficacy.

Growth from this foundation could follow several concrete paths, each hinging on a specific, cited catalyst.

Scenario	What happens	Catalyst	Why it's plausible
Standard for Carbon Projects	RhizoPellets become a recommended or required input for forestry-based carbon credit validation, driving adoption from project developers.	A major carbon registry (e.g., Verra, Gold Standard) publishes a methodology endorsing mycorrhizal inoculation for additionality.	The company's stated mission targets "carbon capture initiatives" and its product is designed for reforestation to "generate your own carbon" [Rhizocore Technologies Ltd]. Early trials provide the necessary field data.
Landowner-Led Vertical Integration	Rhizocore transitions from a product supplier to a managed service provider, offering end-to-end restoration planning and monitoring.	A strategic partnership with a major land management or environmental consultancy to bundle services.	The involvement of The Grosvenor Estate as an investor suggests alignment with landowner operational needs beyond just input supply [Roslin Innovation Centre].
North American Platform Launch	The company uses its US expansion hub in Atlanta to capture share in the larger, well-funded North American restoration market.	Successful pilot projects with US-based timber investment management organizations (TIMOs) or government agencies.	The recent £4.5 million funding round is explicitly allocated to "set up operations in the US" and support North American expansion [GlobeNewswire, Nov 2025].

What compounding looks like for Rhizocore is a data and distribution flywheel. Each new field site generates proprietary data on fungal strain performance across specific soil types, tree species, and climates. This growing dataset improves future product formulations, creating a performance moat that generic mycorrhizal products cannot match. The company cites cultivating fungi from "one of the world's largest living fungal libraries" and tailoring them to specific sites, a process that inherently becomes more valuable with scale [Rhizocore Technologies Ltd]. On the distribution side, a win with a flagship landowner or carbon project creates a powerful reference case, lowering sales friction for similar adjacent customers in the same ecosystem. The planned 10x scale-up of UK production capacity is a tangible step towards supporting this compounding loop [UK Agri-Tech Centre].

The size of the win can be framed by looking at comparable companies in the agricultural biologicals sector. While direct public peers in forestry are scarce, companies like Pivot Bio (microbial nitrogen for row crops) have achieved valuations in the billions of dollars following significant venture funding rounds. A more conservative benchmark is the acquisition multiples seen in adjacent sustainable agriculture. If Rhizocore executes on the "Standard for Carbon Projects" scenario and captures a material portion of the forestry carbon project input market,a market measured in hundreds of millions of dollars annually,a strategic exit to a large agribiological or specialty chemicals company at a revenue multiple comparable to those transactions is a plausible outcome. This represents a scenario, not a forecast, where the company's value scales with its adoption as a critical, branded component of high-value environmental asset creation.

Data Accuracy: YELLOW -- Growth scenarios and flywheel mechanics are inferred from company statements and early traction evidence; the core customer and expansion plans are confirmed by multiple sources.

Sources

PUBLIC

1. [Rhizocore Technologies Ltd] Rhizocore Technologies | https://www.rhizocore.com

2. [Edinburgh Innovations] Rhizocore and accelerating woodland regeneration | https://edinburgh-innovations.ed.ac.uk/case-studies/rhizocore

3. [GOV.UK] RHIZOCORE TECHNOLOGIES LTD overview | https://find-and-update.company-information.service.gov.uk/company/SC704085

4. [Roslin Innovation Centre] Biotech firm raises £4.5M for North American expansion | https://www.roslininnovationcentre.com/news/biotech-firm-raises-45m-for-north-american-expansion

5. [GlobeNewswire, Nov 2025] Biotech Firm Raises £4.5M for North American Expansion | https://www.globenewswire.com/news-release/2025/11/19/3190582/0/en/Biotech-Firm-Raises-4-5M-for-North-American-Expansion.html

6. [Scottish Enterprise Media Centre] Biotech firm Rhizocore Technologies raises £4.5M for North American expansion | https://www.scottish-enterprise-mediacentre.com/news/biotech-firm-rhizocore-technologies-raises-gbp-4-5m-for-north-american-expansion

7. [UK Agri-Tech Centre] Fungi-powered forestry restoration: Rhizocore secures millions for tree growth innovation | https://ukagritechcentre.com/news/fungi-powered-forestry-restoration-rhizocore-secures-millions-tree-growth-innovation

8. [The Scottish Farmer] Rhizocore secures £4.5m to transform tree planting | https://www.thescottishfarmer.co.uk/diversification/forestry/25720020.rhizocore-secures-4-5m-transform-tree-planting/

9. [Mossy Earth] Restoring Forest Fungi | https://www.mossy.earth/projects/restoring-forest-fungi